Article in Science signaling, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed.
Deletion ofFrontiers in cellular neuroscience · 2026
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
16 authors.
Kwun Nok Mimi ManDepartment of Pharmacology, University of California, Davis, CA 95616-8636, USA.ORCID 0000-0002-0132-9129
Sarah L S RougéDepartment of Pharmacology, University of California, Davis, CA 95616-8636, USA.ORCID 0000-0003-0041-103X
Ruben A BerumenDepartment of Pharmacology, University of California, Davis, CA 95616-8636, USA.
Ariel A JacobiDepartment of Pharmacology, University of California, Davis, CA 95616-8636, USA.
Justin C WeinerDepartment of Pharmacology, University of California, Davis, CA 95616-8636, USA.ORCID 0000-0003-1999-6277
Shawheen Y NaderiDepartment of Statistics, University of California, Davis, CA 95616-5270, USA.
Kyle E IretonDepartment of Pharmacology, University of California, Davis, CA 95616-8636, USA.ORCID 0000-0003-1575-8968
Zoila M Estrada-TobarDepartment of Pharmacology, University of California, Davis, CA 95616-8636, USA.ORCID 0000-0002-4212-5325
Zhuoer ZengDepartment of Pharmacology, University of California, Davis, CA 95616-8636, USA.ORCID 0009-0001-7483-8290
Joseph M MartinezDepartment of Pharmacology, University of California, Davis, CA 95616-8636, USA.ORCID 0000-0001-9024-4209
Yang K XiangDepartment of Pharmacology, University of California, Davis, CA 95616-8636, USA.ORCID 0000-0003-1786-9143
Madeline Nieves-CintrónDepartment of Pharmacology, University of California, Davis, CA 95616-8636, USA.ORCID 0000-0003-1935-8400
Manuel F NavedoDepartment of Pharmacology, University of California, Davis, CA 95616-8636, USA.ORCID 0000-0001-6864-6594
Peter BartelsDepartment of Pharmacology, University of California, Davis, CA 95616-8636, USA.ORCID 0000-0001-5852-1835
Mary C HorneDepartment of Pharmacology, University of California, Davis, CA 95616-8636, USA.ORCID 0000-0002-2799-3212
Johannes W HellDepartment of Pharmacology, University of California, Davis, CA 95616-8636, USA.ORCID 0000-0001-7960-7531
Funding
UC Davis MCB T32 Administrative Supplement to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) MentorshipT32GM007377 · NIGMS · UNIVERSITY OF CALIFORNIA DAVIS · PI CHEDIN, FREDERIC LOUIS · 1985 to 2023
$9.9M
Coupling of Vascular Cav1.2 Channels In Health & DiseaseR01HL121059 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI NAVEDO, MANUEL F · 2015 to 2024
$4.5M
Training Program in Basic NeuroscienceT32MH082174 · NIMH · UNIVERSITY OF CALIFORNIA AT DAVIS · PI W MARTIN USREY · 2007 to 2026
$3.1M
Cerebral Vascular Smooth Muscle Dysfunction in Alzheimer's DiseaseR01HL149127 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI NAVEDO, MANUEL F · 2019 to 2022
$2.7M
Phosphodiesterases govern nuclear cAMP signaling for gene expressionR01MH134119 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI YANG Kevin XIANG · 2023 to 2026
$2.6M
cAMP signaling in vascular smooth muscle in health and diseaseR01HL161872 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI NAVEDO, MANUEL F · 2022 to 2025
$2.6M
Learning, Memory, and Plasticity (LaMP) Training ProgramT32MH112507 · NIMH · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Karen Zito · 2017 to 2026
$2.4M
Postsynaptic Signaling by Norepinephrine and cAMPR01NS123050 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI JOHANNES W HELL · 2022 to 2026
$2.3M
Predoctoral Training in Pharmacological SciencesT32GM099608 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HELL, JOHANNES W · 2012 to 2021
$2.2M
Training Program in PharmacologyT32GM144303 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Donald M Bers, JOHANNES W HELL · 2022 to 2026
$2.1M
Dysregulation of Cav1.2 by beta amyloid peptideRF1AG055357 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HELL, JOHANNES W · 2022 to 2024
$1.7M
Novel mechanism on subpopulation-dependent biased GPCR signaling in neuronsR01GM129376 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI XIANG, YANG K · 2018 to 2021
Dopamine drives the neuronal activity and synaptic plasticity required for various forms of learning. It supports short-term working memory through activation of the D
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.